Objective: To assess the clinical value of selective hepatic arterial embolization in the management of liver rupture and hemorrhage due to blunt hepatic injury. Methods: The clinical data of 61 patients with blunt liver rupture and hemorrhage treated during August 2009 to February 2012 were retrospectively analyzed. Of the patients, 30 cases received medical therapy only (drug treatment group), while the other 31 cases underwent medication and selective hepatic arterial embolization (interventional group). The opertion conversion rate, average red blood cell transfusion per patient, average length of hospital stay and incidence of complications between the two groups were compared. Results: The differences in gender, age and degree of severity of liver injury between the two groups showed no statistical significance at admission (all P>0.05). Compared with drug treatment group, the operation conversion rate (12.9% vs. 30%), average red blood cell transfusion requirement [(4.2±0.88) U vs. (6.6±1.47) U] and length of hospital stay [(7.2±5.2) d vs. (22.6±4.9)d] in interventional group were decreased significantly (all P<0.05). No significant difference in incidence of complications between the two groups was noted (19.4% vs. 23.3%) (P>0.05). Conclusion: Selective hepatic arterial embolization is a safe and effective treatment modality for liver rupture caused by blunt trauma, with the advantages of stable efficacy, minimal invasiveness and quick recovery.